Docetaxel

Journal of Clinical Oncology P

14 years ago

Taxane Induced Peripheral Neuropathy: A Continued Challenge but Not a Biomarker of Treatment Efficac

docetaxel

paclitaxel

pharmacogenomics

peripheralneuropathy

taxanes

+5

+4

+4

+3

+3

+3

+2

+2

+1

docetaxel

paclitaxel

pharmacogenomics

peripheralneuropathy

taxanes

+5

+4

+4

+3

+3

+3

+2

+2

+1

Journal of Clinical Oncology P

11 years ago

A Positive Study of DTC-Guided Secondary Adjuvant Treatment in Early Breast Cancer: Ready for Prime

cancer

breast

therapy

secondary

docetaxel

+4

+4

+3

+3

+2

+2

+1

cancer

breast

therapy

secondary

docetaxel

+4

+4

+3

+3

+2

+2

+1

Journal of Clinical Oncology P

14 years ago

Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the

docetaxel

gemcitabine

metastaticbreastcancer

chemotherapystrategies

+4

+3

+3

+3

+2

+2

+2

+1

docetaxel

gemcitabine

metastaticbreastcancer

chemotherapystrategies

+4

+3

+3

+3

+2

+2

+2

+1

FirstWord Pharmaceutical News

12 years ago

FirstWord Pharmaceutical News for Monday, June 2, 2014

valeant

allergan

docetaxel

teva

glaxosmithkline

+4

+4

+3

+3

+3

+2

+1

+1

14:34

valeant

allergan

docetaxel

teva

glaxosmithkline

+4

+4

+3

+3

+3

+2

+1

+1